Erwinaze and Pulmonary embolism - a phase IV clinical study of FDA data
Summary:
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Erwinaze?
Erwinaze has active ingredients of asparaginase erwinia chrysanthemi. Currently, eHealthMe is studying from 275 Erwinaze users.
What is Pulmonary Embolism?
Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 3,480 drugs and 2,860 conditions by eHealthMe. Currently, we are studying 155,616 people who have Pulmonary embolism.
Do you take Erwinaze and have Pulmonary embolism?
Check whether Pulmonary embolism is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Erwinaze side effects by duration, gender and age:
- Erwinaze side effects (275 reports)
Pulmonary embolism treatments and more:
- Pulmonary embolism (155,616 reports)
All the drugs that are associated with Pulmonary embolism:
All the conditions that are associated with Pulmonary embolism:
How the study uses the data?
The study uses data from the FDA. It is based on asparaginase erwinia chrysanthemi (the active ingredients of Erwinaze) and Erwinaze (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Celebrex and Breast Cancer In Situ - 3 seconds ago
- Exemestane and Hot Flushes Aggravated - 4 seconds ago
- Fluoxetine and Duodenal Ulcer Aggravated - 5 seconds ago
- Avandaryl and Sertraline Hydrochloride drug interaction - 9 seconds ago
- Pitavastatin and Tymlos drug interaction - 12 seconds ago
- Lokelma and Pleural Effusion - 20 seconds ago
- Estraderm and Maxolon drug interaction - 23 seconds ago
- Accuretic and Joint Pain - 25 seconds ago
- Benadryl and Personality Disorder - 26 seconds ago
- Digoxin and Impaired Driving Ability - 35 seconds ago